Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
23.00    0.00 (0.00%)
Bid:
22.00
Ask:
24.00
Spread: 2.00 (9.091%)
Market Cap: £24.84m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Derivative Claim - Update

18 Jun 2015 08:50

RNS Number : 5360Q
Elektron Technology PLC
18 June 2015
 



Elektron Technology plc 

("Elektron" or the "Company")

 

Derivative Claim - Update

 

In its 2015 Annual Report, on page 18, the Company provided an update in relation to the derivative litigation brought by a shareholder, Mr Bridge, who holds at the date of this announcement 1.83% of the Company's ordinary shares.

On 16 and 17 June 2015 Mr Bridge's application for permission to continue the intended claim against certain current directors, Keith Daley and John Wilson, and certain former directors, Noah Franklin and Simon Acland, (together "the Directors") was considered by the High Court in the Liverpool District Registry.

 

Mr Bridge represented himself at the hearing and both the Company and the Directors were represented by counsel instructed by their respective solicitors.

Permission has been refused by His Honour Judge Hodge QC with the effect that, subject to rights of appeal, the Derivative Claim will not continue.

In his judgment refusing permission, and addressing the Company's case, Judge Hodge QC was entirely satisfied that this was a clear case where the Court should refuse permission. The nature and strength of the claim, in light of the evidence of the Directors and the difficulty in establishing loss to the Company, were such that no reasonable director would support continuation of the litigation.His Lordship was satisfied that the Court should not compel the Company to continue the litigation when disinterested shareholders were not in support, and neither was the independent board.The Judge, having noted that a failure to properly and impartially consider the Company's evidence was a feature that had permeated all of Mr Bridge's submissions, accepted the Company's submission that the way Mr Bridge had conducted the litigation meant that it would not be appropriate to allow him to conduct litigation on the Company's behalf, or to require the Company to lend its name to the action.Mr Bridge has been ordered to pay all the costs of the Company and the Directors. He must make payments on account in the sums of £40,000 (in respect of the Company's costs) and £50,000 (in respect of the costs of the Directors) by close of business on 15 July 2015. Further, costs incurred after the wasted hearing on 1 October 2014 have been awarded on the indemnity basis as, by that time and with the benefit of legal representation, Mr Bridge should have seen the action as doomed for failure. His decision to continue it took the case "outside the commercial norm".

Mr Bridge did not apply for permission to appeal at the hearing, but he has 21 days from 17 June 2015 to do so. Any application for permission would need to be made to the Court of Appeal, setting out his grounds.Further updates will be provided in due course as appropriate.

 

 

For further information:

 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

Andy Weatherstone - Chief Financial Officer

Martin Reeves - Company Secretary

finnCap

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

 

 

Notes to Editors

 

Elektron conceives, designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas:

 

· Demand for ubiquitous power and data: Connectivity Solutions

· Internet of Things, cloud computing and mobile devices: enabling automation and management of a new wave of business processes: Checkit

· Growth in high precision manufacture: Nano-positioning

· Healthcare for the ageing population: Ophthalmology

· Connected customer experiences and service delivery: E-Commerce and E-Service

 

In addition, Elektron owns a portfolio of well-established products and brands which provide customer access and feedback.

 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSDRAITLIE
Date   Source Headline
23rd Aug 20114:53 pmRNSDirector/PDMR Shareholding
23rd Aug 20114:46 pmRNSHolding(s) in Company
12th Aug 20117:00 amRNSIssue of Scrip Dividend Shares
29th Jul 20113:01 pmRNSDirector/PDMR Shareholding
29th Jul 20117:01 amRNSAppointment of Chief Financial Officer
29th Jul 20117:00 amRNSResult of AGM and Change of Name
28th Jul 20117:00 amRNSTrading Update
12th Jul 20115:02 pmRNSHolding(s) in Company
30th Jun 20114:58 pmRNSDoc re. Company's Scrip Dividend Scheme
28th Jun 20113:36 pmRNSAnnual Financial Report and Notice of AGM
16th Jun 20111:43 pmRNSHolding(s) in Company
19th May 201110:32 amRNSHolding(s) in Company
16th May 201112:03 pmRNSDirector/PDMR Shareholding
12th May 20117:00 amRNSPreliminary Results
12th Apr 20117:00 amRNSTechnology Update
10th Mar 20117:00 amRNSPre-Close Trading Update
1st Feb 20117:00 amRNSDirector/PDMR Shareholding
31st Jan 201110:24 amRNSDirector/PDMR Shareholding
20th Jan 20119:51 amRNSDirector/PDMR Shareholding and Total Voting Rights
13th Jan 20117:00 amRNSIssue of Equity
17th Dec 20107:00 amRNSTrading Statement
14th Dec 20108:42 amRNSHolding(s) in Company
2nd Dec 20107:00 amRNSHolding(s) in Company
15th Nov 20102:26 pmRNSDirectorate Change
9th Nov 20103:27 pmRNSHolding(s) in Company
5th Nov 20102:24 pmRNSHolding(s) in Company
5th Nov 20107:00 amRNSHolding(s) in Company
4th Nov 20107:00 amRNSDirector/PDMR Shareholding
1st Nov 20104:59 pmRNSHolding(s) in Company
27th Oct 201010:47 amRNSDirector/PDMR Shareholding
27th Oct 201010:47 amRNSDirector/PDMR Shareholding
5th Oct 20103:47 pmRNSDirector/PDMR Shareholding
27th Sep 20102:26 pmRNSDirector/PDMR Shareholding
24th Sep 20107:00 amRNSCompulsory Acquisition Procedure
23rd Sep 20104:32 pmRNSIssue of Equity
17th Sep 20107:00 amRNSIssue of Equity
16th Sep 20104:42 pmRNSHolding(s) in Company
16th Sep 20107:00 amRNSHalf Yearly Report
15th Sep 20101:54 pmRNSDirectorate Change
15th Sep 20107:15 amPRNProposed Cancellation from AIM Close of Offer
15th Sep 20107:00 amRNSOffer Update: Close of Offer
8th Sep 20107:00 amRNSNotification of Interim Results
24th Aug 201011:11 amRNSOffer Document Posted
12th Aug 201012:37 pmRNSDirectorate Change
6th Aug 20102:30 pmRNSDirector/PDMR Shareholding
6th Aug 20102:29 pmRNSHolding(s) in Company
6th Aug 20107:00 amRNSHolding(s) in Company
6th Aug 20107:00 amRNSDirectorate Change
5th Aug 20109:56 amRNSIssue of Equity
2nd Aug 20101:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.